Cutler Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Cutler Investment Counsel's ABBV Position: Q2 2026 in Review
Cutler Investment Counsel reduced its AbbVie (ABBV) stake by 7.4% in Q2 2026, selling an estimated $43K and leaving 2,488 shares worth $626K. The position accounts for 0.06% of the portfolio, ranked #102.
Cutler Investment Counsel first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $818K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cutler Investment Counsel held 2,488 shares of AbbVie worth $626K as of Q2 2026.
- Cutler Investment Counsel sold 200 AbbVie shares in Q2 2026, an estimated $43K.
- AbbVie made up 0.06% of Cutler Investment Counsel's portfolio in Q2 2026, its #102 holding.
- Cutler Investment Counsel first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Cutler Investment Counsel's AbbVie position peaked at $818K in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cutler Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.